Goettingen, Germany – Effective January 1, 2011, the former Millipore executive, Dominique Baly, has assumed cross-divisional management of marketing,

Gene Logic, an Ocimum Biosolutions company, a leading provider of genomic solutions, is pleased to

Prosensa, the Dutch based biopharmaceutical company focusing on RNA modulating therapeutics, announces the appointment of Berndt Modig as

November 09 – TRIN Pharma GmbH, specializing in the development of small molecule drugs for tumor treatment, has announced that effective October 6, 2009, Dr. Stefan Wohlfeil has

Nov. 3 – Rosetta Genomics, Ltd. (Nasdaq: ROSG), a leading developer of microRNA-based molecular diagnostics, today announced the appointment of Kenneth A. Berlin

Nov. 2 – The Ensign Group, Inc. (NASDAQ:ENSG), the parent company of the Ensign(TM) group of skilled nursing, rehabilitative care services, hospice care and assisted living companies, today today announced that Gregory K. Stapley,

February 5 – QIAGEN today announced that Gisela Orth has joined the Company as Vice President Global Human Resources on February 2nd.

January 26 – QIAGEN N.V. today announced that Stephane Perrey has joined the Company as President of its fully-owned subsidiary QIAGEN KK on January 1, 2009. He follows Kazuo Tokushige, who

January 19- QIAGEN today announced that Tom Clement has joined the Company as Vice President Regulatory and Clinical Affairs on January 12, 2009. In his new position, he will direct and coordinate

May 27 – Informed Medical Communications (IMC), a leading provider of peer-to-peer medical forums for the bio-pharmaceutical industry, today announced the appointment of Bert Marchio to the position of Executive Vice President/Chief Financial Officer.